Evidence supporting the use of: Bifidobacterium infantis
For the health condition: Enteritis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Bifidobacterium infantis is a probiotic bacterium commonly found in the gut microbiota of infants. It has been investigated for its potential to support or treat enteritis, which refers to inflammation of the intestine, often caused by infection or other disruptions of the gut barrier. Scientific studies, both in animal models and in clinical settings, have shown that B. infantis may help reduce intestinal inflammation, restore a healthy microbial balance, and improve gut barrier function.

Several randomized controlled trials and preclinical studies have demonstrated that B. infantis supplementation can reduce the severity and duration of enteritis—especially in cases such as necrotizing enterocolitis (NEC) in preterm infants and antibiotic-associated diarrhea. The mechanisms proposed include modulation of the immune response, competitive inhibition of pathogenic bacteria, and production of short-chain fatty acids that nourish colonocytes and lower inflammation.

However, while the evidence is promising, it is not yet definitive. Many studies are small or have methodological limitations, and not all forms of enteritis have been equally studied. Nevertheless, there is a growing body of scientific validation for the use of B. infantis in managing certain types of enteritis, particularly in vulnerable populations such as infants. The overall evidence strength is moderate, warranting a rating of 3 out of 5.

More about Bifidobacterium infantis
More about Enteritis